Early recombinant human epidermal growth factor treatment recovers the irradiation-induced decrease of Na+ absorption prior to the definite histological mucositis - 29/10/10
pages | 6 |
Iconographies | 4 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Recombinant human epidermal growth factor (rhEGF) has potential benefit for the mucositis induced by radiation therapy as a therapeutic setting. In this study, we aimed to investigate the effects of rhEGF treatment on the radiation-induced changes in epithelial transport function, before the occurrence of the definitive histological mucosal changes. C3H/He mice received 0, 4, or 8 Gy irradiation and/or EGF treatment (rhEGF 0, 1 and 5mg/kg, i.p., 5 days). At day 7, we recorded short circuit current (Isc) of the upper tracheal epithelium using the flow-type Ussing chamber method, with histological analysis. As a result, there was no evident pathological change in the epithelium from the irradiated and/or rhEGF treated mice at day 7. The initial level of Isc and amiloride-sensitive Isc (ΔIsc,Amil) were decreased after 8 Gy irradiation, reflecting suppression of basal Na+ absorption. The decreased ΔIsc,Amil was recovered by rhEGF treatment. In conclusion, epithelial Na+ channel-dependent basal Na+ absorption was primarily affected by irradiation, before the pathological changes. The recovery of basal Na+ absorption (ΔIsc,Amil) suggested a potentially beneficial effect of early rhEGF treatment for irradiation-induced suppression of the upper aerodigestive epithelial functions.
Le texte complet de cet article est disponible en PDF.Keywords : Radiation, Epidermal growth factor, Epithelium, Short circuit current, Ion transport
Plan
Vol 64 - N° 9
P. 594-599 - novembre 2010 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?